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Abstract
Bovine mastitis remains the most common and costly disease of dairy cattle worldwide. A complementary control
measure to herd hygiene and vaccine development would be to selectively breed cattle with greater resistance to
mammary infection. Toll-like receptor 1 (TLR1) has an integral role for the initiation and regulation of the immune
response to microbial pathogens, and has been linked to numerous inflammatory diseases. The objective of this
study was to investigate whether single nucleotide polymorphisms (SNPs) within the bovine TLR1 gene (boTLR1)
are associated with clinical mastitis (CM).
Selected boTLR1 SNPs were analysed within a Holstein Friesian herd. Significant associations were found for the
tagging SNP -79 T > G and the 3’UTR SNP +2463 C > T. We observed favourable linkage of reduced CM with
increased milk fat and protein, indicating selection for these markers would not be detrimental to milk quality.
Furthermore, we present evidence that some of these boTLR1 SNPs underpin functional variation in bovine TLR1.
Animals with the GG genotype (from the tag SNP -79 T > G) had significantly lower boTLR1 expression in milk
somatic cells when compared with TT or TG animals. In addition, stimulation of leucocytes from GG animals with
the TLR1-ligand Pam3csk4 resulted in significantly lower levels of CXCL8 mRNA and protein.
SNPs in boTLR1 were significantly associated with CM. In addition we have identified a bovine population with
impaired boTLR1 expression and function. This may have additional implications for animal health and warrants
further investigation to determine the suitability of identified SNPs as markers for disease susceptibility.
Introduction
Bovine mastitis is an inflammatory udder disease of
great economic importance to the dairy industry. Masti-
tis is caused mainly by intramammary bacterial infection
hence effective disease control measures rely upon farm
management practices to limit the duration of infection
a n dt or e s t r i c tc o n t a g i o u ss pread of pathogens through
the herd. As a result of these control measures opportu-
nistic pathogens such as Escherichia coli and Streptococ-
cus uberis predominate, and are now the leading cause
of mastitis in the UK and common causes of mastitis
worldwide [1]. Vaccination programmes may be
required to further control mastitis [2], however no
effective vaccines are currently available. An additional
long term and complementary strategy is the genetic
selection of cattle that are less prone to mastitis. A lack
of phenotypic data on clinical mastitis (CM) limits many
breeding programmes, which select on the basis of a
lowered somatic cell count (SCC) as a surrogate of CM
[3]. The correlation between basal SCC and CM con-
tinues to be questioned [4,5] and the elucidation of
more accurate genetic risk factors for CM is required.
The identification of single nucleotide polymorphisms
(SNPs) within genes involved with the mammary innate
immune response are receiving particular interest as
DNA markers for CM susceptibility [6-9].
The innate immune system provides an early defence
to microbial pathogens [10] and involves cell surface
proteins from the Toll-like receptor (TLR) family. TLRs
are a structurally conserved type I membrane-bound
class of pathogen recognition receptor (PRR), that can
differentiate between an array of pathogen-associated
molecular patterns (PAMPs) [11,12]. Functional expres-
sion of TLRs on resident mammary immune cells and
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tion and control of innate immune responses towards
mastitis-causing bacteria [13-16]. Ten functional bovine
(bo) TLRs have been characterised (Coffey et al. unpub-
lished) [17], revealing close identity to their human
orthologues [18]. Each individual TLR possesses its own
ligand recognition repertoire, and upon stimulation acti-
vate internal adaptor proteins to initiate signalling for
the NFB-mediated production of pro-inflammatory
cytokines including the chemokine CXCL8 [19]. During
mastitis, CXCL8 production increases rapidly [20] pro-
viding a potent chemotactic gradient to promote neutro-
phil movement into the mammary gland, a vital early
defence mechanism against infection.
The presence of SNPs within mammalian TLRsh a s
been shown to predispose susceptibility to a number of
inflammatory diseases [21-23]. TLR1 variants have been
postulated to underlie the altered immune responses to
a wide spectrum of bacterial pathogens. In humans, a
non-synonymous TLR1 SNP located within the trans-
membrane domain, which had an impact on TLR1 traf-
ficking, NFB activity and cytokine output, was found to
have strong associations with susceptibility to and pro-
gression of infection by Gram positive bacteria and
Mycobacterium leprae [24,25]. Polymorphisms affecting
boTLR1 may therefore predispose excessive or poor
immune responses to pathogens and hence could confer
an increased risk of mammary infection.
Mammalian TLR1 is a member of a unique TLR sub-
family that includes TLR6 and TLR10. All have the abil-
ity to form heterodimers with TLR2 to expand the
repertoire of recognised ligands. TLR1/TLR2 complexes
mediate cellular responses to natural triacylated lipopro-
tein structures [26,27], which are cell wall constituents
of Gram-positive and Gram-negative bacteria [28].
TLR6/TLR2 complexes expand ligand recognition to
diacylated lipoproteins, although in cattle the boTLR1/
TLR2 complex may be further activated by diacylated
lipoproteins [29]. Whilst more investigation is required
to uncover their function, TLR10/TLR2 complexes may
extend recognition of TLR1 agonists via an unknown
signalling mechanism [30]. Phylogenetic analysis of
boTLR1, 6 and 10 reveals common ancestry with all
three genes located in tandem to form a ~69 kb TLR6-
TLR1-TLR10 gene cluster on Bos taurus chromosome 6
(bta6) [31]. Genome-wide quantitative trait locus (QTL)
studies reveal the boTLR6-TLR1-TLR10 gene cluster to
be situated within a dense QTL region for a number of
milk production traits and CM [32,33]. Furthermore,
boTLR1 has been highlighted as a strong candidate for
underlying QTL regions for disease resistance such as
mastitis [34].
Despite strong QTL evidence, associative studies
between boTLR1 and mastitis are limited. The boTLR1
coding sequence (CDS) is highly polymorphic, contain-
ing many SNPs across several cattle breeds [35]. Four
SNPs within the CDS of boTLR1 were identified in Hol-
stein cows [36], but only one non-synonymous SNP,
located within the transmembrane domain, was reported
to result in highly significant differences in SCC
between all genotype populations. More investigation is
required to verify such studies, and to establish associa-
tions with novel boTLR1 SNPs/haplotypes. More impor-
tantly, the ability to use data indicating actual CM
incidence, rather than a surrogate such as SCC, and
associate this with specific genetic markers has the
potential to yield more accurate information.
We report the identification of boTLR1 SNPs within
coding and non-coding regions, and their potential as
genetic markers for mastitis. We further demonstrate
evidence of variable receptor response between defined
boTLR1 SNP genotypes.
Materials and methods
Ethics statement
All experiments conformed to local and national guide-
lines on the use of experimental animals.
Sample population
The herd of Holstein Friesian cows used during this
project (Mayfield Dairy, Institute for Animal Health,
Compton, UK) contributes to the National Milk Records
(NMR) [37] which submits production records for each
animal to a database accessed through the InterHerd
software programme (University of Reading/PAN Live-
stock services team, UK). This, along with health data
held locally, provided comprehensive information for
each cow within the herd. All animal data were recorded
within the years 2001-2010, during which, the mean CM
incidence for the milking herd was 60 cases per 100
cows per year.
Isolation and extraction of genomic DNA from milk
somatic cells
Milk samples (50 mL) were held on ice prior to centri-
fugation (3000 g; 5 min; 4°C). Supernatants were care-
fully removed along with any residual fat layer.
Remaining casein micelles were removed using an
adaptation of a procedure devised previously [38]. In
brief, cell pellets were re-suspended in 1.5 mL PBS/
EDTA solution (1 mL PBS, 300 μL 0.5 M EDTA and
200 μL TE buffer - 10 mM-Tris-HCl-1 EDTA pH 7.6),
mixed well and allowed to stand at room temperature
(RT) for 10 min. Cells were re-pelleted by centrifuga-
tion (7000 g; 1 min; RT), the supernatant discarded
and cells re-suspended in 1.5 mL of TE buffer. Cells
were pelleted again (7000 g; 1 min) and resuspended in
200 μLP B S .
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DNeasy blood and tissue kit for genomic DNA isolation
(Qiagen Ltd, Sussex, UK). Briefly, 20 μLp r o t e i n a s eK
solution (Qiagen Ltd.) was added to resuspended cells
and mixed well before being incubated overnight at 4°C.
To ensure RNA-free genomic DNA, 4 μLR N a s eA( 1 0 0
mg/mL) was added following overnight incubation and
samples left for 2 min at RT. DNA was extracted using
the column protocol according to manufacturer’s
instructions (Qiagen Ltd). The quantity and quality of
DNA was analysed using a NanoDrop 8000 spectrophot-
ometer (Thermo Scientific, USA) and agarose gel
electrophoresis.
Identification and sequencing of sample population for
boTLR1 SNPs
BoTLR1-specific primers for PCR amplification of coding
and non-coding genomic regions were designed based on
the Bos taurus genome annotation build: Btau_4.0
(NC_007304.4). Sequencing of PCR amplicons from a
DNA pool comprising animals with high (greater than
six lifetime CM cases) or no mastitis case histories was
initially chosen as a method of accelerating detection of
disease-associated SNPs. Selected animals were unrelated
and shared similar ages and lactation histories. PCR was
performed using DreamTaq™ DNA polymerase (Fer-
mentas UK, York, UK) following the manufacturer’sp r o -
tocol. Sequencing of purified PCR products was carried
out using BigDye Terminator v3.1 Cycle Sequencing Kit
(Applied Biosystems, Warrington, UK). Samples were
sequenced by capillary electrophoresis on an ABI PRISM
310 Genetic Analyser (Applied Biosystems), and analysed
using the Sequencher™package version 4.1.4 (Gene
Codes Corporation, Ann Arbor, MI, USA). All primers
(Additional file 1) were designed using Primer3 software
[39] and synthesised by Sigma-Genosys Ltd. (Haverhill,
UK). All boTLR1 SNP offsets are given relative to their
position (bp) from the A nucleotide of the ATG codon.
Sequencing of PCR amplicons was extensively used to
genotype the herd population.
Restriction fragment length polymorphism (RFLP) - PCR
analysis
In addition to sequencing of PCR amplicons, SNPs +798
C > T and +1762A > G were genotyped using RFLP
analysis of PCR products; whereby restriction enzyme
MboII cuts in the presence of the C allele for SNP +798
C > T, and restriction enzyme BclI cuts only in the pre-
sence of the A allele (Isoleucine) for the non-synon-
ymous SNP +1762A > G; as described previously [36].
Restriction digests were performed in a final volume of
20 μLc o n t a i n i n g1 0μL PCR product and 2U of appro-
priate restriction enzyme. Digests were incubated at the
recommended temperature for 2 h, with a subsequent
heat inactivation of enzyme at 65°C for 20 min. Homo-
zygous and heterozygous samples, confirmed by sequen-
cing, were included as controls.
Identifying associations between SNPs and clinical
mastitis and milk quality
Identified SNPs were correlated to health or milk produc-
tivity trait data available through the InterHerd software
programme and NMR data. These included CM case his-
tories, milk SCC, mean 305 d milk yields and mean milk
protein/fat concentrations. All Animal data were recorded
within and up to, the first three lactations only. Median
SCC was transformed logarithmically as NEWSCC =
LOG2 (SCC/100 000) + 3. This model accounts for the
skewness of data distribution as used previously [3]. CM
was analysed for presence or absence of cases across the
entire milking tenure of their first three lactations. Mean
incidence of CM is presented as cases per cow per year
([total number of cases/total number of milking days]*365)
within the first three lactations. CM was defined as an indi-
vidual clinically apparent event, coupled with a rise in milk
SCC and/or isolation of pathogen, recorded on a single day
within any/all quarters during a lactation period. Repeated
cases within the same quarter were noted but only
regarded as a new case after seven days return to milking.
Statistical analysis
Genotypic frequencies were tested for deviation from
Hardy-Weinberg equilibrium according to Chi^2 test
and level of significance at 1 degree of freedom. Haplo-
types and linkage disequilibrium (LD) scores (based on
the r
2 statistic), were analysed using the Haploview pro-
gramme [40]. Owing to substantial positive skewness
(due to zero values) of data distribution, mean CM rate
was transformed: NEWCM = LOG10 (CM + 1). A gen-
otypic model was used for separate genotype pair-wise
comparisons. One-way analysis of variance (ANOVA)
and Tukey’s multiple comparisons for CM rate, milking
traits and functional data means, were performed using
Prism
® 5.04 software (Graph Pad Software, Inc, CA,
USA). Presence of any CM event across all lactations
(CM recorded = 1, no recorded CM = 0) between geno-
types were pair-wise tested for significance by a Chi^2
odds ratio test using Minitab
® 16 software (Minitab Sta-
t i s t i c a lS o f t w a r e ,I n c ,P A ,U S A ) .C a l c u l a t i o no fP e a r s o n
correlation coefficients between factors and analysis of
CM response in a General linear model (GLM) was per-
formed using Minitab
® 16 software.
Isolation of polymorphonuclear leukocytes from bovine
blood
For stimulation assays, polymorphonuclear leukocytes
(PMNs) were isolated from 50 mL blood samples of
healthy, age-matched, genotyped cattle that had recorded
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ple collection. Briefly, blood was collected into EDTA
(final concentration of ~1.5%w/v), centrifuged at RT (15
min; 1000 g) and the plasma and buffy coat phases care-
fully removed. For every 2.5 g of lower blood phase, 10
mL of H2O was added. The mixture was agitated and left
for 40 s before adding half the water volume of NaCl/PO4
reagent (2.7% NaCl/PO4 reagent: 2.7 g NaCl into 10 mL
0.132 M phosphate buffer (18.74 g Na2HPO4 and 17.96 g
KH2PO4 into 1 L H2O, pH 6.8) and made up to 100 mL
with H2O) to restore the isotonic strength. PMNs were
pelleted by centrifugation (125 g; 10 min; RT), the super-
natant discarded and the cells re-suspended in 1.5 mL of
PBS. This was repeated twice to wash the cells. Typically 1
×1 0
8 PMN cells were obtained per 50 mL sample. FACS
analysis of polymorphic PMN samples suggested little dif-
ference in cell populations and purity obtained from the
different genotypes.
Isolated PMNs were seeded to 1 × 10
6/1 mL in RPMI
1640 + GlutaMAX™with 10% foetal calf serum (FCS)
(both Invitrogen Ltd. UK) and 100 units mL
-1/100 μg
mL
-1 Penicillin/Streptomycin (Sigma, St Louis, MO,
USA). Prior to stimulation, seeded cells were incubated
at 37°C, in 5% CO2 for approximately 18 h in 24 well
tissue culture plates.
Stimulation of PMNs with TLR ligands
All TLR ligands (InvivoGen, San Diego, CA, USA) were
reconstituted in sterile endotoxinfree water according to
the manufacturers’ instructions, to a concentration of 1
mg mL
-1, and stored at 20°C. The synthetic TLR1-speci-
fic ligand PAM3 was added to the cells in 100 μL of cul-
ture media, at final concentrations of 100 ng/mL, 250
ng/mL and 500 ng/mL. A media control (containing no
ligand) was used. LPS (100 ng/mL) was used as a non-
TLR1 stimulant. Stimulated cells (4 h and 8 h post sti-
mulation) were lysed and total RNA extracted. Superna-
tants were taken 24 h post stimulation for detection of
cytokine production by ELISA.
RNA isolation and cDNA synthesis
Pelleted cell samples were lysed in RLT buffer for total
RNA extraction using the RNeasy mini kit (Qiagen Ltd)
according to manufacturer’s instructions. Samples were
DNase treated (DNAfree, Ambion, Austin, TX, USA)
and analysed for quantity and quality. Total RNA was
used for cDNA synthesis using SuperScript II Reverse
Transcriptase (Invitrogen Ltd. UK) using the recom-
mended protocol. Quantification of cDNA was carried
out using the NanoDrop 8000 spectrophotometer.
Q-PCR analysis
Quantitative PCR (Q-PCR) was performed with the ABI
Prism 7500 FAST Sequence Detection System (Applied
Biosystems) using FAST Universal Mastermix (Applied
Biosystems) according to the manufacturer’sp r o t o c o l .
Taqman
® probe and primers for GAPDH, CXCL8 and
Bcl2A1 have been designed previously [41-43]. Taqman
®
probe and primers for boTLR1 were designed from
sequenced templates, avoiding any SNPs, using the Pri-
mer3 software [39] (Forward: 5’-GCA CCA CAG TGA
GTC TGG AA -3’, Reverse: 5’GTA CGC CAA ACC
AAC TGG AG -3’,P r o b e :5 ’-TGT GTG CTT GAT
GAT AAT GGG TGT CCT -3’). All primers and probes
were synthesised by Sigma-Genosys Ltd. and Eurogentec
Ltd. (Romsey, UK) respectively. Probes were labelled at
the 5’ end with the reporter dye FAM (6-carboxyfluores-
cein) and at the 3’ end with the quencher dye TAMRA
(6-carboxytetramethylrhodamine). 100 ng of cDNA tem-
plate from each animal were tested in triplicate and
quantified by comparison with a standard curve from
plasmid DNA of known copy number. Relative target
gene expression was then calculated by normalising to
the mean expression levels of the housekeeping genes
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
and ribosomal protein, large, P2 (RPLP2). Analysis was
performed using Microsoft
® Excel 2008 (Microsoft Co.,
Redmond, WA, USA) and Prism
® 5.04 software. Differ-
ences between groups were assessed by one-way analysis
of variance (ANOVA) and Tukey’sm u l t i p l e
comparisons.
ELISA
Levels of CXCL8 were determined by luminescent
ELISA, using a pair of commercial human IL-8 specific
antibodies (R&D Systems, Oxon, UK) according to a
modified luminescence-based ELISA described pre-
viously [44]. Samples were tested in triplicate, with
recombinant bovine CXCL8 (Kingfisher Biotech, Inc.,
MN, USA) as the standard. Levels of bovine IL-6 were
determined using a commercial TMB ELISA kit accord-
ing to the manufacturer’s protocol (Thermo Fisher
Scientific, Inc. USA). Differences between groups were
assessed by one-way analysis of variance (ANOVA) and
Tukey’s multiple comparisons.
Results
Characterisation of boTLR1 SNPs
The genomic organisation of boTLR1 was confirmed
using internal cDNA sequencing, and analysis of EST
data submitted to the NCBI database. As described pre-
viously [31], the full length boTLR1 mRNA transcript
comprises five exons and four introns. The CDS for full
length boTLR1; a 2379 bp transcript corresponding to a
793aa chain [45], is located within exon 5. Sequencing
of boTLR1 within a Holstein Friesian herd (n = 246)
revealed eleven SNPs; five of which are novel (Table 1).
Eight of the eleven SNPs were exonic, six were located
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change (+1762A > G, Iso > Val) positioned within the
transmembrane domain, while the remaining two were
located in the non-coding 3’UTR. The three non-exonic
SNPs were identified within the introns of the 5’ UTR
(Figure 1).
Genotypes and allelic frequencies
Five boTLR1 SNPs: -79 T > G, +798 C > T, +1762A >
G, +2463 C > T, and +2731A > G (Figure 1) were
detected within the herd (n = 156, 246, 125, 225 and
232 respectively). The genotypic and allelic frequen-
cies for each SNP are similar, with heterozygotes the
most abundant genotypes (Table 2). All SNPs were
found to be in agreement with Hardy-Weinberg equi-
librium. The three SNPs -79 T > G, +798 C > T, and
+2731A > G were in strong linkage disequilibrium
(LD = > 0.9) (Figure 2) and as a result only the SNP
-79 T > G was used for association analysis. LD
between the tagging SNP -79 T > G and the non-
synonymous +1762A > G was moderate (LD = ~0.8).
LD between SNPs -79 T > G and +2463 C > T was
lower. The lowest LD was observed between SNPs
+1762A > G and +2463 C > T (Figure 2). Conse-
quently, analysis of association with traits for SNPs
-79 T > G, +1762A > G and +2463 C > T was per-
formed individually. Preliminary haplotype construc-
tion for SNPs 79 T > G, +798 C > T, +1762A > G,
+2463 C > T, and +2731A > G, yielded two major
haplotypes of G79T798A1762C2463G2731 (frequency 0.42)
and T79C798G1762T2463A2731 (frequency 0.41) (under-
lined allele denotes change from the published
Btau_4.0 sequence NC_007304.4). Owing to the low
number of individuals typed for all five markers (n =
125), haplotype association analysis was not
performed.
Analysis of boTLR1 SNPs with clinical mastitis
The three boTLR1 SNPs -79 T > G, +1762A > G and
+2463 C > T were analysed in Holstein Friesian cows
for association with CM and milk production traits.
Analysis of the tagging SNP -79 T > G revealed the TG
and GG genotypes associated with an increased rate of
CM (0.75 and 0.70 cases/cow/year, respectively) com-
pared with the TT genotype (0.40 cases/cow/year)
(Table 3). The association with CM rate was found to
be significantly (P < 0.05) higher for the heterozygote
(TG) population, the most abundant genotype, when
compared with homozygote (TT) animals. The propor-
tion of animals within each genotyped population having
any episodes of CM during their first three lactations
was highest in the GG genotype (70%) compared with
TT and TG genotypes (58% and 60%, respectively),
although this was found not to be statistically signifi-
cant. Analysis of the non-synonymous, transmembrane
domain SNP; +1762A > G, showed AA and AG animals
had higher rates of CM (0.69 and 0.66 cases/cow/year,
respectively) compared with GG animals (0.38 cases/
cow/year), although these differences were not signifi-
cantly different. Analysis of the SNP +2463 C > T
located within the 3’UTR revealed that CC and CT ani-
mals had higher rates of CM (0.70 cases/cow/year) com-
pared to TT animals (0.39 cases/cow/year). However,
only the increase seen in the most abundant genotype,
heterozygous CT cows, was shown to be statistically sig-
nificant (P < 0.05).
Association of boTLR1 SNPs with milk productivity traits
Analysis of the productivity traits within the genotyped
animals revealed that the TG and GG genotypes of the
tagging SNP -79 T > G associated significantly with low-
ered milk fat (TG = P <0 . 0 5 ,G G=P < 0.01) and pro-
tein (TG = P <0 . 0 1 ,G G=P < 0.001) concentrations
Table 1 Identified SNPs within boTLR1 from Holstein Friesians.
SNP Genomic (bta6) position Amino acid position Amino acid Restriction site presence Previously reported dbSNP ID
-1205A > G 60440366 - - - No -
-1151T > A 60440312 - - - No -
-79T > G 60439240 - - - No -
+798 C > T 60438363 266 Phe-Phe MboII Yes
1 ss73689409
+1641A > C 60437520 547 Ser-Ser Bst X-I Yes
2 ss73689413
+1716 G > A 60437445 572 Lys-Lys Bsi Y Yes
2 ss73689414
+1762A > G 60437324 587 Ile-Val Bcl I Yes
2 ss73689415
+2100 C > T 60436989 700 Phe-Phe - Yes
2 ss73689417
+2103 T > C 60436986 701 Val-Val BsmAI Yes
2 ss73689418
+2463 C > T 60436698 - - MsII No -
+2731A > G 60436430 - - - No -
Abbreviations: bta6 = Bos taurus chromosome 6, dbSNP = Single-Nucleotide Polymorphism Database [46]. All boTLR1 sequences were aligned with the published
Btau_4.0 sequence NC_007304.4 (underlined allele denotes the published sequence). Light shading - synonymous coding SNPs, dark shading -non-synonymous
coding SNP. All boTLR1 SNP offsets are given relative to their position (bp) from the A nucleotide of the first ATG codon.
1 [31],
2 [35].
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(Table 3). A similar trend was detected in the genotypes
of the SNP +1762A > G; AA and AG genotypes asso-
ciated with lower milk fat and protein concentrations;
however these differences were not statistically signifi-
cant. Analysis of genotypes within the SNP +2463 C >
T revealed that CT and CC genotypes produced milk
with lower protein concentration (P < 0.05) when com-
pared with the TT population. The same genotypes
tended to show lower milk fat concentration, but these
differences were not significant. No differences in either
milk yield or mean SCC were detected between any of
Figure 1 Schematic diagram showing the positions of identified SNPs within the bovine TLR1 gene. Open box represents coding exon
(CDS = 2379 bp), grey boxes represent non-coding untranslated exonic regions (UTR). A TLR1 protein domain architecture diagram, designed
using web-based programmes [47,48], is illustrated below the CDS. The non-synonymous +1762A > G SNP (in bold), is located within the
transmembrane domain (vertical black bar). LRR - leucine-rich repeat domains (19 in total), LRR C -leucine-rich repeat C terminal domain, TIR -
Toll-Interleukin 1-resistance domain. Sequence shown from Btau_4.0 sequence (NC_007304.4), bta6: 60355 k-60363 k. Boxed SNPs have been
sequenced extensively for trait associations.
Table 2 Genotype and allele frequencies including significance from Hardy-Weinberg equilibrium for boTLR1 SNPs
selected for trait association.
SNP Genotype n = Genotype Frequency HWE Allele Allele Frequency
-79 T > G TT 53 0.34 0.831 T 0.568
TG 71 0.46 G 0.432
GG 32 0.20
+798 C > T
1 CC 78 0.32 0.885 C 0.543
CT 122 0.49 T 0.456
TT 46 0.19
+1762A > G
1 AA 33 0.26 0.326 A 0.495
GA 57 0.46 G 0.505
GG 35 0.28
+2463 C > T CC 64 0.28 0.163 C 0.507
CT 102 0.46 T 0.493
TT 59 0.26
+2731A > G AA 77 0.33 0.611 A 0.546
AG 110 0.48 G 0.454
GG 45 0.19
1SNPs genotyped by RFLP-PCR. HWE not significant at 1 degree of freedom.
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Multiple comparisons
Correlation coefficient analysis was performed revealing
a weak positive correlation between CM and SCC (Pear-
son coefficient = 0.198) and weak negative correlations
between CM and milk fat and milk protein percentages
(Pearson coefficient = -0.2 and -0.1 respectively). All sig-
nificant associations between individual SNP genotypes
and CM were found to survive adjustments for each fac-
tor using a General linear model (GLM).
Q-PCR analysis of basal boTLR1 mRNA abundance
Milk somatic cells from cows with representative
boTLR1 -79 T > G SNP genotypes were assessed for dif-
ferences in basal boTLR1 expression. All animals were
of similar age and stage of lactation and none had any
known health issues. Q-PCR assays were performed
using RNA from five animals of each genotype. Cows
with the GG genotype demonstrated lower boTLR1
mRNA abundance (P <0 . 0 1 )c o m p a r e dw i t he i t h e rt h e
TT or TG genotypes (Figure 3). Due to close homology
and potential for co-expression, the abundance of
boTLR6 mRNA was also measured and revealed no sig-
nificant differences.
Variation in immune responses to a TLR1 ligand
Cells from twelve animals (four from each representative
boTLR1 -79 T > G SNP genotype) were stimulated for
up to 24 h with the ligand Pam3csk4 (PAM3), which has
an affinity for TLR1/TLR2 heterodimers [49]. CXCL8
and IL-6 mRNA abundance and CXCL8 and IL-6 pro-
duction were used as markers for TLR1 stimulation. Q-
PCR analysis indicated that animals with the GG geno-
type had lower levels of CXCL8 mRNA 4 h post-stimu-
lation with PAM3 compared to equivalent samples from
animals with either of the TT or TG genotypes (Figure
4). Samples from animals that were homozygous TT
showed significantly greater (P < 0.05) CXCL8 mRNA
abundance 4 h after stimulation with PAM3 at concen-
trations of 250 and 500 ng/mL when compared to GG
homozygotes (Figure 4a). Homozygous TT animals
tended to show greater IL-6 abundance 4 h after stimu-
lation however no significant differences were detected
between genotypes across all ligand concentrations (data
not shown). A similar trend in CXCL8 and IL-6 data
was observed from cells stimulated for 8 h (data not
shown). Animals that were homozygous TT displayed
significantly greater (P < 0.05) IL-6 mRNA abundance 8
h after stimulation with PAM3 at 500 ng/mL when com-
pared to GG homozygotes (data not shown).
The mRNA abundance of the anti-apoptotic factor
Bcl2A1was used as an additional marker to indicate dif-
ferences in TLR1 stimulation. Following stimulation
with PAM3, Q-PCR analysis showed greater levels of
Bcl2A1 mRNA in animals with the TT genotype com-
pared to those with either the TG or GG genotypes
(Figure 4b). Significantly (P < 0.05) greater levels of
mRNA were detected in samples from animals with the
TT genotype compared to those with the TG genotype
following stimulation with PAM3 at 250 ng/mL and 500
ng/mL. In contrast, a statistically significant difference
between the TT and GG genotypes was only detected
following stimulation at the higher concentration.
Supernatants (24 h post-stimulation) were assayed for
CXCL8 and IL-6 production by ELISA. CXCL8 data
showed a similar trend to those obtained by Q-PCR,
with significantly (P < 0.05) lower levels of CXCL8 pro-
duced by cows with the GG genotype than those with
the TT genotype following stimulation with 500 ng/mL
PAM3 (Figure 5a). Individual variation was largest
within those samples from TG heterozygotes, with
Figure 2 Linkage disequilibrium (LD) plot for five extensively
genotyped SNPs in relation to the boTLR1 gene model. Open
box represents boTLR1 coding exon, grey boxes represent non-
coding untranslated (UTR) exonic regions. The non-synonymous
amino acid change is shown in brackets below corresponding
coding SNP. The graphical representation, generated by Haploview,
of the r
2 LD relationship between each SNP is expressed on a gray-
scale gradient; where black - very high LD (r
2 = 1.0) and white -
very low LD (< 0.1). The r
2 value for each pair-wise comparison is
shown, where no value is indicated r
2 =1 .
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variability in CXCL8 production. IL-6 data showed sig-
nificantly (P < 0.05) lower levels produced by cows with
the GG genotype than the TT genotype following stimu-
lation with 500 ng/mL PAM3 (Figure 5b). Overall
stimulation with TLR1 ligand across all concentrations
did not increase cytokine production in GG variants.
The TLR4 ligand LPS was used to assess if the detected
v a r i a t i o ni nr e s p o n s et oP A M 3 reflected the ability of
the cell populations to respond to any ligand. The
response to LPS was variable across all genotypes and
did not segregate by the defined genotypes (Additional
file 2).
Discussion
In this study we analysed five SNPs within exonic and
non-exonic regions of boTLR1 for susceptibility to CM.
We identified significant associations between the tagging
SNP -79 T > G, and the 3’UTR SNP +2463 C > T and
susceptibility to CM. Rates of CM for genotypes -79 TT
and +2463 TT were much lower in comparison to the
homozygous genotypes (-79 GG and +2463 CC) and sig-
nificantly lower than their respective heterozygous geno-
types. The CM rate differences observed between defined
genotypes can have a significant impact on both herd
welfare and farm expenditure. For example, the -79 TT
animals recorded on average 40 CM cases per 100 cows
per year, below the historic national average for England
and Wales, which has been estimated at 47 cases [1]. GG
and TG animals recorded 70 and 75 cases respectively, a
substantial increase from the national average. As a sim-
ple economic evaluation, if estimated average costs for a
clinical case are £175 [50] potential losses per 100 cows
when compared to TT animals equate to £6125 and
£5250 for TG and GG animals respectively.
Table 3 Analysis of boTLR1 SNP genotypes by CM and milk productivity traits over the first three lactations.
SNP Gen. n = P% with
CM
1
Mean CM
rate
2
P=
3
Median
SCC
4
P=
3
Mean 305 d milk
yield
4
P=
3
Mean milk
fat (%)
4
P=
3
Mean milk
protein (%)
4
P=
3
tag-79 T
>G
TT 78* 58% 0.40 (±
0.11)
1.96 (±
0.63)
7868 (± 1181) 4.15 (± 0.41) 3.28 (± 0.19)
TG 122* 60% 0.75 (±
0.18)
<
0.05
1.85 (±
0.61)
- 8058 (± 1139) - 4.02 (± 0.38) <
0.05
3.2 (± 0.17) <
0.01
GG 46* 70% 0.70 (±
0.24)
- 1.98 (±
0.67)
- 7983 (± 1273) - 3.89 (± 0.41) <
0.01
3.16 (± 0.18) <
0.001
+1762A
>G
AA 33 63% 0.69 (±
0.27)
- 1.96 (±
0.64)
- 8101 (± 1106) - 3.95 (± 0.41) - 3.19 (± 0.18) -
GA 57 61% 0.66 (±
0.18)
- 1.89 (±
0.69)
- 8067 (± 1330) - 4.04 (± 0.45) - 3.21 (± 0.2) -
GG 35 59% 0.38 (±
0.16)
1.90 (±
0.62)
8239 (± 1185) 4.05 (± 0.38) 3.25 (± 0.16)
+2463 C
>T
CC 64 67% 0.70 (±
0.24)
- 1.95 (±
0.66)
- 7841 (± 1067) - 4.02 (± 0.45) - 3.19 (± 0.18) <
0.05
CT 102 61% 0.70 (±
0.14)
<
0.05
1.90 (±
0.63)
- 8137 (± 1206) - 3.98 (± 0.45) - 3.18 (± 0.2) <
0.05
TT 59 59% 0.39 (±
0.11)
1.88 (±
0.63)
7940 (± 1262) 4.13 (± 0.38) 3.27 (± 0.18)
Abbreviations: Gen. = genotype, P% = population percentage, CM = clinical mastitis, SCC = somatic cell count. * Numbers from tagged SNP +798 C > T in Table
2.
1No significance was detected between genotypes by Chi^2 odds ratio test.
2Mean ± 95% confidence interval given in column parentheses.
3P values analysed
by ANOVA and Tukey’s multiple comparisons, showing only results tested against the underlined (lower CM rate) genotype; - (dash) denotes no significance.
4Standard deviation from the mean given in column parentheses.
Figure 3 Q-PCR data showing basal mRNA abundance levels of
boTLR1 and boTLR6 in milk somatic cells grouped into the
three boTLR1 -79 T > G SNP variant populations: TT, TG and
GG. Data from each variant population (n = 5) is presented as a box
and whisker plot, with the ends of the whiskers representing the
minimum and maximum data values. Grey box plot - TT animals,
hatched box plot - TG animals, and open box plot - GG animals. **
Genotypic means differ significantly (P < 0.01 by ANOVA and
Tukey’s multiple comparisons).
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Page 8 of 12Dairy cows are subjected to intense selection pressures
for higher milk yields and reduced SCC that may unin-
tentionally be detrimental to CM incidence [5]. How-
ever, in this study, no significant differences were
observed between boTLR1 SNPs for mean 305 d milk
yields or SCC. This contradicts a study of 208 Chinese
Holsteins, in which the non-synonymous SNP +1762A >
G associated with highly significant differences in milk
SCC. Animals with an AA (Isoleucine) at this position
had lower SCC and were classed as more resistant to
mastitis [36]. In contrast, our results suggest the GG
(Valine) at this location is the more favourable genotype
in terms of having a lower CM incidence in comparison
to AA. Although this discrepancy may reflect breed and
herd variation, it may also demonstrate the dichotomy
that the surrogate measure of mastitis is also the pre-
sence of the effector cell which can at times eliminate
infection in the absence of overt clinical signs.
All boTLR1 SNP genotypes associated with a lowered
rate of CM display significantly greater milk fat and pro-
tein concentrations when compared to the other two
genotypes. It is unclear whether a functional association
exists between milk fat and protein concentrations and
mastitis susceptibility. Interestingly the casein gene clus-
ter is located ~28 Mb from the TLR6-TLR1-TLR10 gene
cluster on bta6 [51]. Protein and fat contents are finan-
cially rewarded milk qualities and breeding for these fac-
tors could influence boTLR1 genotypes.
In addition to being one of the first studies to examine
association between boTLR1 SNPs and CM incidence,
we further demonstrate evidence of variable receptor
Figure 4 Q-PCR data following stimulation with the TLR1
ligand PAM3 in bovine PMNs grouped into the three boTLR1
-79 T > G SNP variant populations: TT, TG and GG. Q-PCR data
of CXCL8 (A) and Bcl2A1 (B) mRNA abundance following +4 h
stimulation. Data from each variant population (n = 4) is presented
as a box and whisker plot, with the ends of the whiskers
representing the minimum and maximum data values. Grey box
plot - TT animals, hatched box plot - TG animals, and open box plot
- GG animals. *Genotypic means differ significantly (P < 0.05 by
ANOVA and Tukey’s multiple comparisons).
Figure 5 ELISA data following stimulation with the TLR1 ligand
PAM3 in bovine PMNs grouped into the three boTLR1 -79 T >
G SNP variant populations: TT, TG and GG. ELISA data of
CXCL8 (A) and IL-6 (B) production following + 24 h stimulation.
Data from each variant population (n = 4) is presented as a box
and whisker plot, with the ends of the whiskers representing the
minimum and maximum data values. Grey box plot - TT animals,
hatched box plot - TG animals, and open box plot - GG animals. *
Genotypic means differ significantly (P < 0.05 by ANOVA and
Tukey’s multiple comparisons).
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Page 9 of 12responses between the defined genotypes. In this study
animals segregated by -79 T > G SNP genotypes exhib-
ited significantly lower boTLR1 expression in GG ani-
mals when compared with TT or TG. This difference,
which appeared to be specific for boTLR1 as it was not
seen for boTLR6 a paralogue of boTLR1,m a yi n d i c a t e
interference with transcription. Although more variable,
intermediate basal expression levels observed in TG
cows suggests that the presence of a T allele is compen-
sating for the lowered expression originating from the G
allele. Preliminary analysis for causal mutations using
the programme MOTIF [52] highlighted the -79 T > G
SNP as part of an Octamer-1 (Oct-1) motif. Oct-1 is
thought to work closely with AP-1 and GATA-1 as
important regulatory elements for TLR expression [53].
However the motif was only identified with the T var-
iant (threshold > 80%), and was absent in those with the
G substitution. Although this is an attractive hypothesis
i ti sa l s op o s s i b l et h a tt h eS N Pm a ys i m p l yb eam a r k e r
for other unidentified causal mutations.
Currently there are no boTLR1 antibodies available to
directly compare levels of protein expression. To ascer-
tain the functional consequence of potentially reduced
boTLR1 expression, production of cytokines known to
be induced by TLR1 was determined from cells stimu-
lated with the TLR1 ligand PAM3. Our study demon-
strated genotype-specific variation in cytokine responses
of bovine PMN to PAM3. Across all time points and
ligand concentrations analysed, PAM3 stimulation of
cells from animals segregated by tagging -79 T > G SNP
genotypes revealed lower levels of CXCL8 and IL-6
mRNA and protein from those of a GG genotype and
consistently high CXCL8 and IL-6 response from those
with TT genotypes. The output of cytokines from cells
from the TG animals was the most variable. The NFB-
transcribed gene [54] encoding the pro-survival protein
Bcl2A1, which is up-regulated in neutrophils following
stimulation with TLR ligands including PAM3 [55], was
used as an additional marker of effective boTLR1 stimu-
lation. Significantly greater levels of the Bcl2A1 tran-
script were detected in animals with the TT genotype
compared to those with the TG or GG genotypes. All
genotypes were also stimulated with LPS, and no differ-
ences were detected in levels of CXCL8 or IL6. This
further indicates that differences observed following sti-
mulation with PAM3 were influenced by variation in the
response via boTLR1.
PMNs contain a high proportion of neutrophils,
whose primary role is the phagocytosis of microbes to
contain and eliminate infection. However stimulated
neutrophil TLRs further induce the neutrophil to
synthesise cytokines that influence their own activity
and survival, recruit additional immune cells and modu-
late the immune response [56-59]. The greater
expression of Bcl2A1 in animals with the TT genotype
may promote PMN survival to complement the
increased cytokine output. Reduced boTLR1 stimulation
by pathogens in GG cows may equate to a dampened
inflammatory response thus enabling establishment and
persistence of infection. In terms of influence upon mas-
titis susceptibility, GG cows have a higher CM rate than
TT cows; however heterozygous TG cows have a similar
rate to GG cows, despite expressing boTLR1 at a similar
level to a TT cow. TG animals showed intermediary
cytokine responses to TLR1 ligand, and like GG animals,
lower expression of Bcl2A1. This may suggest that dif-
ferences in boTLR1 transcript levels alone may not
account for the variation in receptor response, and/or
that post-transcriptional control of translation may also
be affected by the cumulative presence of SNPs. The
animals used for the functional assays conform to
observed haplotypes: TT = T79C798G1762T2463A2731 and
GG = G79T798A1762C2463G2731; with TG animals hetero-
zygous for each SNP. In terms of the likelihood of being
causative of a variable TLR1 response, the non-synon-
ymous SNP +1762 Iso > Val is an unlikely candidate.
Both Isoleucine and Valine are non-polar branched
amino acids with hydrophobic properties, and so a sub-
stitution within the transmembrane domain should not
impact the tertiary structure; although further targeted
structure/function studies are required to verify this.
Furthermore, influence of polymorphisms within TLR-
related or target genes such as TLR2 and CXCL8 should
be considered.
In conclusion the findings presented here demonstrate
an association between SNPs, common to boTLR1,a n d
CM susceptibility. Furthermore, we present evidence
that some of these SNPs underpin functional variation
in boTLR1. A rapid immune response, conferred by the
favourable boTLR1 SNP -79 TT variant, could reduce
detrimental clinical manifestations of diseases via an
efficient yet controlled influx of inflammatory cells to
neutralise pathogens and control infection. The com-
plexity of mastitis infection suggests a polygenic and
multi-factorial immune response comprising many dif-
ferent proteins which will in turn interact with one
another. The ability to detect significant associations
with CM for a single gene indicates the importance of
boTLR1 related responses in the control of bacterial dis-
ease in cattle. A bovine population with impaired
boTLR1 e x p r e s s i o nm a ya l s ob em o r es u s c e p t i b l et o
other diseases and health issues. Preliminary evidence
for this comes from our study where it was observed
that animals with the GG variant seemed to be prema-
turely culled compared to other populations.
The potential of SNPs within boTLR1 to act as genetic
markers for altered susceptibility to mastitis warrants
further investigation. The favourable linkage of lowered
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Page 10 of 12CM with increased milk fat and protein concentrations
in the boTLR1 variants demonstrated here indicates
selection for lowered CM using these markers would
not be detrimental to milk quality, as has been pre-
viously suggested in studies linking SNPs with increased
SCC as a marker for CM susceptibility.
Additional material
Additional file 1: Primers used for PCR amplification of boTLR1
genomic regions, RFLP PCR digests, and quantitative PCR (QPCR)
assays.
Additional file 2: Table to show expression levels of CXCL8 and Bcl2
A1 and CXCL8 and IL-6 production levels following PMN
stimulation with LPS.
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